Drugs for Microvascular Complications of Diabetes 3 (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 297)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Captopril |
Approved |
Phase 4 |
|
62571-86-2 |
44093 |
Synonyms:
(2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylate
(2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid
(2S)-1-[(2S)-2-Methyl-3-sulphanylpropanoyl]pyrrolidine-2-carboxylate
(2S)-1-[(2S)-2-Methyl-3-sulphanylpropanoyl]pyrrolidine-2-carboxylic acid
(S)-1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline
Acediur
Aceplus
Acepress
ACEPRIL
Alopresin
Apopril
C09AA01
Capoten
Capoten®|SQ-14225
Captolane
CAPTOMEX
CAPTOPRIL
Captoprilum
Captoprilum [INN-Latin]
Captopryl
Captoril
Cesplon
|
CP
D-2-Methyl-3-mercaptopropanoyl-L-proline
D-3-Mercapto-2-methylpropanoyl-L-proline
Dilabar
ECOPACE
Garranil
Hipertil
Hypertil
HYTENEZE 12.5
HYTENEZE 25
HYTENEZE 50
KAPLON
L-Captopril
Lopirin
LOPRIL
NOYADA
SA-333
SQ -14225
SQ-14225
Tenosbon
Tensobon
Tensoprel
|
|
2 |
|
Clopidogrel |
Approved |
Phase 4 |
|
120202-66-6, 113665-84-2 |
60606 |
Synonyms:
(+)-(S)-Clopidogrel
(+)-Clopidogrel
(S)-Clopidogrel
BMS Brand 1 OF clopidogrel bisulfate
BMS Brand 2 OF clopidogrel bisulfate
CLOPIDOGREL
Clopidogrel [Ban:Inn]
Clopidogrel besilate
Clopidogrel besylate
Clopidogrel bisulfate
Clopidogrel bisulphate
Clopidogrel hydrochloride
CLOPIDOGREL HYDROGEN SULFATE
Clopidogrel mepha
Clopidogrel napadisilate
|
Clopidogrel sandoz
CLOPIDOGREL SULFATE
Clopidogrel, (+)(S)-isomer
Clopidogrel-mepha
Clopidogrelum
GREPID
Iscover
Isocover
Plavix
PLAVIX®
R 130964
R-130964
SR 25990
SR-25990
SR-25990C
|
|
3 |
|
Vildagliptin |
Approved, Investigational |
Phase 4 |
|
274901-16-5 |
6918537 |
Synonyms:
(2S)-(((3-Hydroxyadamantan-1-yl)amino)acetyl)pyrrolidine-2-carbonitrile
EQUA
Galvus
Galvus®|LAF-237|NVP-LAF237
Jalra
LAF 237
LAF237
LAF-237
|
NVP LAF237
NVP-LAF 237
NVP-LAF237
NVP-LAF-237
Vildagliptin
Vildagliptina
Xiliarx
|
|
4 |
|
Moxonidine |
Approved, Investigational |
Phase 4 |
|
75438-57-2 |
4810 |
Synonyms:
(2R,4R)-1-[(2S)-5-[(AMINOIMINOMETHYL)AMINO]-1-OXO-2-[[(1,2,3,4-TETRAHYDRO-3-METHYL-8- QUINOLINYL)SULFONYL]AMINO]PENTYL]-4-METHYL-2-PIPERIDINECARBOXYLIC ACID
4-Chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-6-methoxy-2-methyl-5-pyrimidinamine
BDF5896
BDF-5896
BE5895
BE-5895
Cynt
FISIOTENS
Lilly brand OF moxonidine
LY326869
LY-326869
|
Moxon
Moxonidin
Moxonidina
MOXONIDINE
Moxonidinum
NORCYNT
Normatens
NUCYNT
Physiotens
Solvay brand OF moxonidine
Zint
|
|
5 |
|
Alprostadil |
Approved, Investigational |
Phase 4 |
|
745-65-3 |
5280723 |
Synonyms:
(-)-3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-cyclopentaneheptanoate
(-)-3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-cyclopentaneheptanoic acid
(-)-Prostaglandin e1
(+)-3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-cyclopentaneheptanoate
(+)-3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-cyclopentaneheptanoic acid
(11a,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-Oate
(11a,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-Oic acid
(11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-Oate
(11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-Oic acid
(11Α,13E,15S)-11,15-dihydroxy-9-oxoprost-13-en-1-Oate
(11Α,13E,15S)-11,15-dihydroxy-9-oxoprost-13-en-1-Oic acid
(13E)-(15S)-11,15-Dihydroxy-9-oxoprost-13-enoate
(13E)-(15S)-11,15-Dihydroxy-9-oxoprost-13-enoic acid
(13E)-(15S)-11a,15-Dihydroxy-9-oxoprost-13-enoate
(13E)-(15S)-11a,15-Dihydroxy-9-oxoprost-13-enoic acid
(13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate
(13E)-(15S)-11-alpha,15-Dihydroxy-9-oxoprost-13-enoate
(13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoic acid
(13E)-(15S)-11-alpha,15-Dihydroxy-9-oxoprost-13-enoic acid
(13E)-(15S)-11Α,15-dihydroxy-9-oxoprost-13-enoate
(13E)-(15S)-11Α,15-dihydroxy-9-oxoprost-13-enoic acid
11,15-Dihydroxy-9-oxoprost-13-en-1-Oate
11,15-Dihydroxy-9-oxoprost-13-en-1-Oic acid
11,15-Dihydroxy-9-oxoprost-13-en-1-Oic acid (acd/name 4.0)
11a,15a-Dihydroxy-9-oxo-13-trans-prostenoate
11a,15a-Dihydroxy-9-oxo-13-trans-prostenoic acid
11alpha,15alpha-Dihydroxy-9-oxo-13-trans-prostenoate
11alpha,15alpha-Dihydroxy-9-oxo-13-trans-prostenoic acid
11Α,15α-dihydroxy-9-oxo-13-trans-prostenoate
11Α,15α-dihydroxy-9-oxo-13-trans-prostenoic acid
3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-cyclopentaneheptanoate
3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-cyclopentaneheptanoic acid
7-[(1R,2R,3R)-3-HYDROXY-2-[(1E,3S)-3-HYDROXYOCT-1-EN-1-YL]-5-OXOCYCLOPENTYL]HEPTANOIC ACID
Abbott brand OF alprostadil
Allphar brand OF alprostadil
Alprostadil
ALPROSTADIL ALFADEX
Alprostadil prostoglandin e1
Alprostadil®|MR-256|prostaglandin E<sub>1</sub>
Alprostadil(usan)
Alprostadilum
Astra brand OF alprostadil
AstraZeneca brand OF alprostadil
Befar
|
Caverject
Caverject impulse
Edex
Hoyer brand OF alprostadil
Janssen brand OF alprostadil
lipo PGE1
lipo-PGE1
L-Prostaglandin e1
Minprog
MR-256
Muse
NSC-165559
ONO-1608
Paladin brand OF alprostadil
PGE1
PGE-1
PGE₁
PGE1 Α-CD
PGE1alpha
Pharmacia brand 1 OF alprostadil
Pharmacia brand 2 OF alprostadil
Prink
PRINK (TN)
Prostaglandin e1
Prostaglandin e1alpha
Prostavasin
PROSTIN
Prostin VR
Prostin VR pediatric
Prostine VR
Schwarz brand OF alprostadil
Schwarz pharma brand OF alprostadil
Sugiran
U-10136
U-10136alprostadil
U-10136prostin
Vasaprostan
Viridal
VIRIDAL 10
VIRIDAL 20
VIRIDAL 5
VIRIDAL DUO
Vitaros
Vivus brand OF alprostadil
|
|
6 |
|
Amlodipine |
Approved |
Phase 4 |
|
88150-42-9 |
2162 |
Synonyms:
(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
3-Ethyl 5-methylester, (±)-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate
3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate
3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylic acid
Almirall brand OF amlodipine besilate
Amlocard
Amlodipine
Amlodipine Benzenesulfonate
Amlodipine besilate
Amlodipine besylate
amlodipine besylate|amlodipine maleate|Copalia® (amlodipine + valsartan)|Katerzia® (amlodipine oral suspension, 1 mg/mL)|Norvasc®|UK-4834011
Amlodipine free base
Amlodipine maleate
Amlodipine maleate (1:1)
Amlodipine, (+-)-isomer
Amlodipine, (+-)-isomer, maleate (1:1)
Amlodipine, (R)-isomer
Amlodipine, (S)-isomer, maleate (1:1)
Amlodipino
Amlodipino [Spanish]
Amlodipinum
|
Amlodipinum [Latin]
Amlodis
Amlor
AMVAZ
Astudal
ASTUDAL 5
CKD-330 COMPONENT AMLODIPINE
Coroval
Eczacibasi brand OF amlodipine besilate
HGP0904
HGP-0904
Istin
Lipinox
Lotrel
Mack brand OF amlodipine besilate
NORVAS
Norvasc
Pelmec
Pfizer brand OF amlodipine besilate
Racemic amlodipine
|
|
7 |
|
Atenolol |
Approved |
Phase 4 |
|
29122-68-7 |
2249 |
Synonyms:
1-p-Carbamoylmethylphenoxy-3-isopropylamino-2-propanol
2-(p-(2-Hydroxy-3-(isopropylamino)propoxy)phenyl)acetamide
4-(2-Hydroxy-3-((1-methylethyl)amino)propoxy)benzeneacetamide
Aircrit
Alinor
Altol
Anselol
Antipressan
Apo-atenolol
Atcardil
Atecard
Atehexal
ATENAMIN
Atenblock
Atendol
Atenet
Ateni
Atenil
ATENIX-100
ATENIX-25
ATENIX-50
Atenol
Atenol 1a pharma
Atenol acis
Atenol al
Atenol atid
Atenol cophar
Atenol CT
Atenol fecofar
Atenol gador
Atenol genericon
Atenol GNR
Atenol heumann
Atenol MSD
Atenol NM pharma
Atenol nordic
Atenol PB
Atenol quesada
Atenol stada
Atenol tika
Atenol trom
Atenol von CT
Atenolin
Atenol-mepha
Atenolol
ATENOLOL (JAN/USP)
ATENOLOL [USAN:BAN:INN:JAN]
Atenololum
ATENOLOLUM [INN-LATIN]
Atenol-ratiopharm
Atenol-wolff
Atenomel
Atereal
Aterol
Betablok
Betacard
Betasyn
Betatop ge
Blocotenol
Blokium
C07AB03
Cardaxen
|
Cardiopress
Corotenol
Cuxanorm
Duraatenolol
Duratenol
ESATENOLOL
Evitocor
Farnormin
Felo-bits
Hipres
Hypoten
Ibinolo
ICI 66082
ICI-66082
Internolol
Jenatenol
Juvental
KENTOL
Loten
Lo-ten
Lotenal
Myocord
Myocord®|Normiten®|Tenormin®
Normalol
Normiten
Noten
Oraday
Ormidol
Panapres
Plenacor
Premorine
Prenolol
Prenormine
Prinorm
Scheinpharm atenol
Seles beta
Selobloc
Serten
Servitenol
Stermin
Tenidon
Teno-Basan
Tenobloc
Tenoblock
Tenolol
Tenoprin
Tenoretic
Tenormin
TENORMIN 25
TENORMIN L.S.
Tenormine
TENORMINE [FRENCH]
Tensimin
TOTAMOL
Tredol
Unibloc
Uniloc
VASATEN
Vascoten
Vericordin
Wesipin
Xaten
|
|
8 |
|
Doxazosin |
Approved |
Phase 4 |
|
74191-85-8 |
3157 |
Synonyms:
1 (4-amino-6,7-Dimethoxy-2-quinazolinyl)-4-((2,3-dihydro-1,4-benzodioxin-2-yl)carbonyl)piperazine
1-(4-Amino-6,7-dimethoxy-2-chinazolinyl)-4-(2,3-dihydro-1,4-benzodioxixin-2-ylcarbonyl)piperazin
1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(1,4-benzodioxan-2-ylcarbonyl)piperazin
Alfamedin
Aliud brand OF doxazosin mesylate
Almirall brand OF doxazosin mesylate
Alpharma brand OF doxazosin mesylate
Alter brand OF doxazosin mesylate
apo Doxazosin
apo-Doxazosin
Apogepha brand OF doxazosin mesylate
Apotex brand OF doxazosin mesylate
AstraZeneca brand OF doxazosin mesylate
Azupharma brand OF doxazosin mesylate
Betapharm brand OF doxazosin mesylate
C02CA04
Cantabria brand OF doxazosin mesylate
Cardular
Cardura
Cardura XL
Cardura®|UK-3327427
Carduran
Carduran neo
Ciclum brand OF doxazosin mesylate
Cinfa brand OF doxazosin mesylate
combino Brand OF doxazosin mesylate
CT Arzneimittel brand OF doxazosin mesylate
CT, Doxazosin von
CT-Arzneimittel brand OF doxazosin mesylate
Diblocin
Doxa puren
Doxacor
Doxagamma
Doxamax
Doxa-puren
Doxatensa
DoxaUro
Doxazomerck
Doxazosin
Doxazosin al
Doxazosin apogepha
Doxazosin azu
Doxazosin beta
Doxazosin findusfit
Doxazosin heumann
Doxazosin klast
Doxazosin mesilate
Doxazosin mesylate
Doxazosin monohydrochloride
Doxazosin ratiopharm
Doxazosin stada
Doxazosin von CT
Doxazosin wolff
Doxazosina
|
Doxazosina alter
Doxazosina cinfa
Doxazosina combino pharm
Doxazosina geminis
Doxazosina normon
Doxazosina pharmagenus
Doxazosina ratiopharm
Doxazosina ur
Doxazosine
Doxazosin-ratiopharm
Doxazosinum
Doxazosin-wolff
Esparma brand OF doxazosin mesylate
FindusFit brand OF doxazosin mesylate
Geminis brand OF doxazosin mesylate
Gen doxazosin
Gen-doxazosin
Genpharm brand OF doxazosin mesylate
Heumann brand OF doxazosin mesylate
Hexal brand OF doxazosin mesylate
Juta brand OF doxazosin mesylate
Jutalar
Kade brand OF doxazosin mesylate
Linden brand OF doxazosin mesylate
Merck dura brand OF doxazosin mesylate
Mesylate, doxazosin
Monohydrochloride, doxazosin
MTW Brand OF doxazosin mesylate
MTW Doxazosin
MTW-Doxazosin
neo, Carduran
Normon brand OF doxazosin mesylate
novo Doxazosin
novo-Doxazosin
Novopharm brand OF doxazosin mesylate
Pfizer brand OF doxazosin mesylate
Pharmagenus brand OF doxazosin mesylate
Progandol neo
Q Pharm brand OF doxazosin mesylate
Q-Pharm brand OF doxazosin mesylate
ratio Doxazosin
ratio-Doxazosin
Ratiopharm brand OF doxazosin mesylate
Ratiopharm, doxazosina
Solvay brand OF doxazosin mesylate
Stadapharm brand OF doxazosin
TAD brand OF doxazosin mesylate
UK-33274
UK-3327427
Uriduct
Von CT, doxazosin
Wolff brand OF doxazosin mesylate
Wörwag brand OF doxazosin mesylate
Zoxan
|
|
9 |
|
Acetylsalicylic acid |
Approved, Vet_approved |
Phase 4 |
|
50-78-2 |
2244 |
Synonyms:
2-(ACETYLOXY)BENZOATE
2-(ACETYLOXY)benzoIC ACID
2-Acetoxybenzenecarboxylate
2-ACETOXYBENZENECARBOXYLIC ACID
2-ACETOXYBENZOATE
2-ACETOXYBENZOIC ACID
2-CARBOXYPHENYL ACETATE
8-HOUR BAYER
A.S.A.
A.S.A. Empirin
ACARD
ACENTERINE
Acesal
Acetal
ACETARD
ACETICYL
Acetilsalicilico
Acetilum acidulatum
Acetisal
ACETOL
ACETONYL
ACETOPHEN
Acetophen®|acetylsalicylic acid|Aspirin®
ACETOSAL
ACETOSALIC ACID
ACETOSALIN
Acetoxybenzoic acid
ACETYLIN
Acetylsal
ACETYLSALIC ACID
ACETYLSALICYLATE
ACETYLSALICYLIC ACID
Acetylsalicylsaeure
Acetylsalicylsaure
ACETYLSALICYLSÄURE
ACETYONYL
ACETYSAL
ACETYSALICYLIC ACID
Acid, acetylsalicylic
Acide 2-(acetyloxy)benzoique
ACIDE 2-(ACÉTYLOXY)BENZOÏQUE
Acide acetylsalicylique
ACIDE ACÉTYLSALICYLIQUE
Acido acetilsalicilico
ÁCIDO ACETILSALICÍLICO
Acido O-acetil-benzoico
ACIDUM ACETYLSALICYLICUM
Acimetten
Acisal
ACYLPYRIN
Adiro
ALKA RAPID
Aloxiprimum
ANADIN ALL NIGHT
ANGETTES 75
ASA
Asagran
ASATARD
Ascoden-30
Aspalon
Aspec
ASPERGUM
ASPIRDROPS
ASPIRIN
Aspirina
Aspirine
Aspro
ASPRO CLR
Asteric
Azetylsalizylsaeure
AZETYLSALIZYLSÄURE
BAY1019036
BAYER EXTRA STRENGTH
Bayer Extra Strength Aspirin For Migraine Pain
BENASPIR
Bialpirina
BIALPIRINIA
Bi-prin
BUFFERIN
CAPRIN
CARDIOASPIRINA
Cemirit
Claradin
Clariprin
Colfarit
Contrheuma retard
Coricidin
Crystar
DANAMEP
Decaten
Delgesic
Dispril
DISPRIN CV
|
DISPRIN DIRECT
Dolean pH 8
Duramax
DURLAZA
EASPRIN
ECM
ECOLEN
ECOTRIN
EMPIRIN
ENDOSPRIN
ENDYDOL
ENPRIN
Entericin
Enterophen
Enterosarein
Enterosarine
Entrophen
EQUI-PRIN
Extren
GENCARDIA
Globentyl
Globoid
Helicon
Idragin
Kyselina 2-acetoxybenzoova
Kyselina acetylsalicylova
LEVIUS
Magnecyl
MAX STRGH ASPRO CLR
MEASURIN
Micristin
MICROPIRIN EC
Neuronika
Novid
NSC-27223
NSC-406186
Nu-seals
NU-SEALS 300
NU-SEALS 600
NU-SEALS 75
Nu-seals aspirin
NU-SEALS CARDIO 75
O-(ACETYLOXY)BENZOATE
O-(ACETYLOXY)BENZOIC ACID
O-accetylsalicylic acid
O-ACETOXYBENZOATE
O-ACETOXYBENZOIC ACID
O-Acetylsalicylate
O-ACETYLSALICYLIC ACID
O-CARBOXYPHENYL ACETATE
O-Carboxyphenyl acetic acid
PAYNOCIL
PERSISTIN
PHARMACIN
Pirseal
PLATET
PLATET 300
Polopirin
POLOPIRYNA
POSTMI 300
POSTMI 75
PREMASPIN
RHEUMINTABLETTEN
RHODINE
Rhonal
Salacetin
SALCETOGEN
SALETIN
Salicylate acetate
SALICYLIC ACID ACETATE
Salicylic acid acetic acid
Salicylic acid, acetate
SALOSPIR
Solfrin
SOLPRIN
SOLPRIN ACID
SOLPYRON
Solupsan
Spira-Dine
St. Joseph
St. Joseph Aspirin for Adults
Supac
TASPRIN
TEMPERAL
TOLDEX
TRIAMINICIN
Triple-sal
Vanquish
VAZALORE
Xaxa
Yasta
Zorprin
|
|
10 |
|
Furosemide |
Approved, Vet_approved |
Phase 4 |
|
54-31-9 |
3440 |
Synonyms:
2-Furfurylamino-4-chloro-5-sulfamoylbenzoate
2-Furfurylamino-4-chloro-5-sulfamoylbenzoic acid
2-Furfurylamino-4-chloro-5-sulphamoylbenzoate
2-Furfurylamino-4-chloro-5-sulphamoylbenzoic acid
4-Chloro-5-sulfamoyl-N-furfuryl-anthranilate
4-Chloro-5-sulfamoyl-N-furfuryl-anthranilic acid
4-Chloro-5-sulphamoyl-N-furfuryl-anthranilate
4-Chloro-5-sulphamoyl-N-furfuryl-anthranilic acid
4-Chloro-N-(2-furylmethyl)-5-sulfamoylanthranilate
4-Chloro-N-(2-furylmethyl)-5-sulfamoylanthranilic acid
4-Chloro-N-(2-furylmethyl)-5-sulphamoylanthranilate
4-Chloro-N-(2-furylmethyl)-5-sulphamoylanthranilic acid
4-Chloro-N-furfuryl-5-sulfamoylanthranilate
4-Chloro-N-furfuryl-5-sulfamoylanthranilic acid
4-Chloro-N-furfuryl-5-sulphamoylanthranilate
4-Chloro-N-furfuryl-5-sulphamoylanthranilic acid
Acetic acid potassium salt
Aisemide
Aldalix
Aldic
Aluzine
ALUZINE 20
ALUZINE 40
ALUZINE 500
Anfuramaide
Apo-frusemide
Apo-furosemide
AQUAMED
Aquarid
Aquasin
Arasemide
Beronald
Bioretic
Bristab
Bristurin
Cetasix
Depix
Desal
Desdemin
Di-Ademil
DIHYDROFLUMETHIAZIDE
dihydroflumethiazide|frusemide|Lasix®|methforylthiazidine
Dirine
Disal
Discoid
Disemide
Diucardin
Diumide-K
Diural
Diurapid
DIURESAL
Diuretic salt
Diurin
Diurolasa
Diusemide
Diusil
Diuzol
Dranex
Dryptal
Durafurid
Edemid
Edenol
Eliur
Elodrine
Endural
Errolon
Eutensin
Farsix
Finuret
Fluidrol
Fluss
Franyl
FROOP
FRUMAX
Frumex
Frumide
Frumil
Frusedan
Frusema
Frusemid
Frusemide
Frusemin
Frusenex
Frusetic
Frusid
FRUSOL
Fulsix
Fuluvamide
Fuluvamine
Furanthril
Furanthryl
Furantral
Furantril
Furanturil
Furesis
Furetic
Furex
Furfan
Furix
Furmid
Furo-basan
Furobeta
Furocot
Furodiurol
Furodrix
Furomen
Furomex
Furomide m.d.
Furo-puren
Furorese
Furosan
Furose
Furosedon
Furosemid
Furosemida
Furosemida [INN-Spanish]
Furosemide
|
Furosemide "mita"
Furosemide monohydrochloride
Furosemide monosodium salt
Furosemidu
Furosemidu [Polish]
Furosemidum
Furosemidum [INN-Latin]
Furosemix
Furoside
Furosifar
Furosix
Furoter
Furovite
Fursemid
Fursemida
Fursemide
Fursol
Fusid
Fusidic acid
Golan
Hissuflux
Hydol
Hydrenox
Hydrex
Hydro
Hydroled
Hydro-rapid
Impugan
Jenafusid
Katlex
Kofuzon
Kolkin
Kutrix
Lasemid
Lasex
Lasiletten
Lasilix
Lasix
LASIX (TN)
LASIX RET
Lasix retard
Lasix Special
Laxur
Lazix
LB-502
Leodrine
Less diur
Liside
Logirene
Lowpston
Lowpstron
Luscek
Macasirool
Marsemide
Metflorylthiazidine
METHFORYLTHIAZIDINE
Mirfat
Mita
Moilarorin
Myrosemide
Nadis
Nelsix
Neo-renal
Nephron
Nicorol
Novosemide
NSC-269420
Octan draselny
Odemase
Odemex
Oedemex
Olmagran
Osyrol
Polysquall a
Prefemin
Profemin
Promedes
Promide
Protargen
Puresis
Radisemide
Radonna
Radouna
Retep
Rodiuran
Rontyl
Rosemide
Rosis
Rusyde
Sal diureticum
Salinex
Salix
Salix (brand OF furosemide)
Salurex
Salurid
Saluron
Seguril
Selectofur
Sigasalur
Sisuril
Spirofur
Synephron
TENKOFRUSE
Transit
Trofurit
Uremide
Uresix
Urex
Urex-m
Urian
Uridon
Uritol
Urosemide
Vergonil
Vesix
Yidoli
Zafimida
|
|
11 |
|
Simvastatin |
Approved |
Phase 4 |
|
79902-63-9 |
54454 |
Synonyms:
(+)-Simvastatin
(1S,3R,7S,8S,8AR)-8-{2-[(2R,4R)-4-HYDROXY-6-OXOOXAN-2-YL]ETHYL}-3,7-DIMETHYL-1,2,3,7,8,8A-HEXAHYDRONAPHTHALEN-1-YL 2,2-DIMETHYLBUTANOATE
2,2-Dimethylbutyrate, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8ar)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one
2,2-Dimethylbutyric acid, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8ar)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one
C10AA01
Cholestat
Coledis
Colemin
Corolin
Denan
Eucor
FLOLIPID
Kolestevan
Labistatin
LACERSA
Lipex
Lipinorm
Liponorm
Lipovas
Lodales
Medipo
MK-0733
MK-733
MK-733|Zocor®
Modutrol
Nivelipol
Nor-vastina
Pantok
Pepstatin
RANZOLONT
|
Rechol
Rendapid
Simcor
Simovil
SIMVADOR
SIMVASTATIN
Simvastatin [Usan:Ban:Inn]
SIMVASTATIN HYDROXY ACID
Simvastatin lactone
Simvastatina
Simvastatina [Spanish]
Simvastatine
Simvastatine [French]
Simvastatinum
Simvastatinum [Latin]
Simvotin
Sinvacor
Sinvascor
SIV691
Sivastin
Statin
Synvinolin
Valemia
Vasotenal
Velostatin
Vytorin
Zocor
ZOCOR HEART-PRO
Zocord
|
|
12 |
|
Clonidine |
Approved |
Phase 4 |
|
4205-91-8, 4205-90-7 |
2803 20179 |
Synonyms:
2-((2,6-Dichlorophenyl)imino)imidazolidine
2,6-Dichloro-N-2-imidazolidinylidenebenzenamine
2-[(2,6-Dichlorophenyl)imino]imidazoline
Adesipress
Boehringer ingelheim brand OF clonidine hydrochloride
Catapres
CATAPRES P.L.
CATAPRES TTS 1
CATAPRES TTS 2
CATAPRES TTS 3
Catapres®|Kapvay®
Catapresan
Catapressan
Catapres-TTS
CATAPRES-TTS-1
CATAPRES-TTS-2
CATAPRES-TTS-3
Catarpres
Catarpresan
Catarpres-TTS
Chlofazoline
Chlophazolin
Chlornidinum
Clofelin
Clofenil
Clonidin
Clonidina
Clonidine
Clonidine dihydrochloride
CLONIDINE HCL
Clonidine hydrochloride
|
Clonidine monohydrobromide
Clonidine monohydrochloride
Clonidinhydrochlorid
Clonidinum
Clonidinum [INN-Latin]
Clonistada
Clopheline
CLORPRES
COMBIPRES
DICHLORANILINO IMIDAZOLIN
Dihydrochloride, clonidine
Dixarit
DURACLON
Duraclont
Gemiton
Hemiton
Hydrochloride, clonidine
Ipotensium
Isoglaucon
JENLOGA
KAPVAY
KAPVAY®
Klofelin
Klofenil
Monohydrobromide, clonidine
Monohydrochloride, clonidine
ST 155BS
ST-155
ST-155BS
ST-155-BS
Tenso-Timelets
|
|
13 |
|
Insulin glulisine |
Approved |
Phase 4 |
|
207748-29-6 |
|
Synonyms:
APIDRA
APIDRA SOLOSTAR
HMR1964
HMR-1964
INS APIDRA
INS APIDRA OPTICLIK
|
INS APIDRA OPTISET
INS APIDRA SOLOSTAR
INSULIN GLULISINE
Insulin Glulisine (recombinant DNA origin)
INSULIN GLULISINE RECOMBINANT
Insulina glulisina
|
|
14 |
|
Insulin glargine |
Approved |
Phase 4 |
|
160337-95-1 |
118984454 |
Synonyms:
ABASAGLAR
ABASAGLAR KWIKPEN
ABASRIA
BASAGLAR
HOE-71GT
HOE-901
INS LANTUS
INS LANTUS OPTICLIK
INS LANTUS OPTISET
INS LANTUS SOLOSTAR
INSULIN GLARGINE
INSULIN GLARGINE (RDNA ORIGIN)
|
INSULIN GLARGINE RECOMBINANT
insulin glargine-yfgn
Insulina glargina
LANTUS
LANTUS (INSULIN GLARGINE [RDNA ORIGIN] INJECTION)
LANTUS SOLOSTAR
LY2963016
LY-2963016
MK-1293
TOUJEO
TOUJEO MAX SOLOSTAR
TOUJEO SOLOSTAR
|
|
15 |
|
Lixisenatide |
Approved |
Phase 4 |
|
320367-13-3 |
90472060 16139342 |
Synonyms:
ADLYXIN
Adlyxin®|AVE-0010|Lyxumia®
AQVE-10010
AVE 0010
AVE 010
AVE0010
AVE-0010
AVE-010
DES-38-PROLINE-EXENDINE-4 (HELODERMA SUSPECTUM)-(1-39)-PEPTIDYLPENTA-L-LYSYL-L-LYSINAMIDE
DESPRO38EXENDIN-4(1-39)-LYS6-NH2
|
H-HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPSKKKKKK-NH2
H-HIS-GLY-GLU-GLY-THR-PHE-THR-SER-ASP-LEU-SER-LYS-GLN-MET-GLU-GLU-GLU-ALA-VAL-ARG-LEU-PHE-ILE-GLU-TRP-LEU-LYS-ASN-GLY-GLY-PRO-SER-SER-GLY-ALA-PRO-PRO-SER-LYS-LYS-LYS-LYS-LYS-LYS-NH2
Lixisenatida
LIXISENATIDE
Lixisénatide
LYXUMIA
ZP 10
ZP-10
ZP10A PEPTIDE
|
|
16 |
|
Zaleplon |
Approved, Illicit, Investigational |
Phase 4 |
|
151319-34-5 |
5719 |
Synonyms:
3'-(3-Cyanopyrazolo(1,5-a)pyrimidin-7-yl)-N-ethylacetanilide
3'-(3-Cyanopyrazolo(1,5-alpha)pyrimidin-7-yl)-N-ethylacetanilide
CL-284846
DEA no. 2781
L846
L-846
LJC 10846
LJC-10846
|
N-(3-(3-Cyanopyrazolo(1,5-a)pyrimidin-7-yl)phenyl)-N-ethylacetamide
SKP-1041
Sonata
Starnoc
ZAL-846
ZALEPLON
ZALEPLON CIV
Zelepion
|
|
17 |
|
Tacrolimus |
Approved, Investigational |
Phase 4 |
|
104987-11-3 |
6473866 445643 |
Synonyms:
(-)-FK 506
Anhydrous tacrolimus
Anhydrous, tacrolimus
Cilag brand OF tacrolimus
FK5
FK506
FK-506
FK506|fujimycin|Prograf®|Protopic®
FR-900506
FUJIMYCIN
Fujisawa brand OF tacrolimus
Janssen brand OF tacrolimus
|
K506
LCP-Tacro
Prograf
Prograft
PROTOPIC
Tacarolimus
TACROLIMUS
Tacrolimus anhydrous
tacrolimus hydrate
TACROLIMUS MONOHYDRATE
Tacrolimus, anhydrous
|
|
18 |
|
Miconazole |
Approved, Investigational, Vet_approved |
Phase 4 |
|
22916-47-8 |
4189 |
Synonyms:
1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole
Brentan
CONOFITE
Dactarin
DERMAZOLE
DUMICOAT
Esteve brand OF miconazole
florid(nitrate)|Monistat®|R-14889
Janssen cilag brand OF miconazole
Janssen-cilag brand OF miconazole
Johnston and johnston brand OF miconazole nitrate
LORAMYC
MCZ
MICATIN
|
Miconasil nitrate
Miconazol
Miconazole
Miconazole esteve brand
Miconazole janssen-cilag brand
Miconazole nitrate
Miconazolum
Monistat
MONISTAT-3
MONISTAT-DERM
Nitrate, miconasil
Nitrate, miconazole
NSC-170986
Oravig
VUSION
|
|
19 |
|
Clotrimazole |
Approved, Vet_approved |
Phase 4 |
|
23593-75-1 |
2812 |
Synonyms:
(Chlorotrityl)imidazole
1-((2-Chlorophenyl)diphenylmethyl)-1H-imidazole
1-(a-(2-Chlorophenyl)benzhydryl)imidazole
1-(alpha-(2-Chlorophenyl)benzhydryl)imidazole
1-(O-Chloro-a,a-diphenylbenzyl)imidazole
1-(O-Chloro-alpha,alpha-diphenylbenzyl)imidazole
1-(O-Chlorotrityl)imidazole
1-(O-Chloro-α,α-diphenylbenzyl)imidazole
1-(Α-(2-chlorophenyl)benzhydryl)imidazole
ABTRIM
ACTAVALL
Bay b 5097
BAY-5097
Bayer brand 1 OF clotrimazole
Bayer brand 2 OF clotrimazole
CANDIDEN
Canesten
Canesten 1-day cream combi-pak
Canesten 1-day therapy
Canesten 3-day therapy
Canesten 6-day therapy
CANESTEN AF
Canesten combi-pak 1-day therapy
Canesten combi-pak 3-day therapy
Canesten cream
CANESTEN CRM COMBI
CANESTEN INTERNAL
Canesten solution
CANESTEN VC
Canesten®|Lotrimin®
Canestine
Chlotrimazole
Clotrimaderm
Clotrimaderm cream
Clotrimazol
CLOTRIMAZOLE
Clotrimazole schering brand
Clotrimazolum
Desamix F
Empecid
FB b 5097
Fem care
FemCare
FUNGEDERM
GNF-PF-3499
Gyne lotrimin
Gyne-lotrimin
Gyne-lotrimin 3
Gyne-lotrimin 3 combination pack
Gyne-lotrimin combination pack
Gyne-lotrimin3
Gyne-lotrimin3 combination pack
|
Gynix
Kanesten
Klotrimazole
Lopac-C-6019
Lotrimax
Lotrimin
LOTRIMIN (TN)
Lotrimin af
Lotrimin af cream
Lotrimin af jock-itch cream
Lotrimin af lotion
Lotrimin af solution
Lotrimin cream
Lotrimin lotion
Lotrimin solution
Lotrisone
MASNODERM
mono-Baycuten
Monobaycuten
Mycelax
Mycelex
MYCELEX (TN)
Mycelex 7
Mycelex cream
Mycelex g
Mycelex otc
Mycelex solution
Mycelex troches
Mycelex twin pack
Mycelex: mycosporinrimazole
Mycelex-7
Mycelex-7 combination pack
Mycelex-g
MYCIL GOLD
Myclo cream
Myclo solution
Myclo spray solution
Myclo-gyne
Mycosporin
Mykosporin
Neo-zol cream
NSC-257473
Otomax
Pedisafe
Prestwick_120
PRIVACOM
Rimazole
Schering brand OF clotrimazole
Tibatin
Trimysten
Trivagizole 3
Veltrim
|
|
20 |
|
Carbamide peroxide |
Approved |
Phase 4 |
|
124-43-6 |
|
Synonyms:
Carbamide peroxide
Hydrogen peroxide carbamide
Urea dioxide
|
Urea hydrogen peroxide
Urea peroxide
|
|
21 |
|
Candesartan cilexetil |
Approved |
Phase 4 |
|
145040-37-5 |
|
Synonyms:
1-(Cyclohexylocarbonyloxy)ethyl-2-ethoxy-1-(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)-1H-benzimidazole-7-carboxylate
1-{[(cyclohexyloxy)carbonyl]oxy}ethyl 2-ethoxy-1-{[2'-(2H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}-1H-1,3-benzodiazole-7-carboxylic acid
1-Cyclohexyloxycarbonyloxyethyl 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylic acid
Amias
Atacand
Blopress
CANDESARTAN
|
Candesartan cilexetil
Kenzen
Parapres
RATACAND
TCV 116
TCV-116
|
|
22 |
|
Nisoldipine |
Approved |
Phase 4 |
|
63675-72-9 |
4499 |
Synonyms:
Bay K 5552
BAY-K-5552
ISOBUTYL METHYL 2,6-DIMETHYL-4-(2-NITROPHENYL)-1,4-DIHYDROPYRIDINE-3,5-DICARBOXYLATE
Nisoldipin
NISOLDIPINA
NISOLDIPINE
NISOLDIPINO
|
NISOLDIPINUM
Sular
Sular®
SYSCOR MR 10
SYSCOR MR 20
SYSCOR MR 30
|
|
23 |
|
Prednisone |
Approved, Vet_approved |
Phase 4 |
|
53-03-2 |
5865 |
Synonyms:
1,2-Dehydrocortisone
1,4-Pregnadiene-17a,21-diol-3,11,20-trione
1,4-Pregnadiene-17alpha,21-diol-3,11,20-trione
1,4-Pregnadiene-17α,21-diol-3,11,20-trione
17,21-Dihydroxypregna-1,4-diene-3,11,20-trione
Acis brand OF prednisone
Acsis, prednison
Adasone
Ancortone
Apo-prednisone
Apotex brand OF prednisone
Aventis brand OF prednisone
Betapar
Bicortone
Cartancyl
Colisone
Cortan
Cortancyl
Cortidelt
Cotone
Cutason
Dacorten
Dacortin
Decortancyl
Decortin
Decortisyl
Dehydrocortisone
Dekortin
Delcortin
Dellacort
Dellacort A
Delta Cortelan
Delta E
Delta-cortelan
Deltacortene
delta-Cortisone
Deltacortisone
Deltacortone
Delta-cortone
DELTA-DOME
Deltasone
Deltison
Deltisona
Deltisone
Deltra
Diadreson
Di-Adreson
Diba brand OF prednisone
Econosone
Encorton
Encortone
Enkortolon
Enkorton
Fawns and mcallan brand OF prednisone
FERNISONE
Ferring brand OF prednisone
Fiasone
GALENpharma brand OF prednisone
Halsey drug brand OF prednisone
Hexal brand OF prednisone
Hoechst brand OF prednisone
Hostacortin
ICN brand OF prednisone
Incocortyl
In-Sone
Juvason
Kortancyl
Lichtenstein brand OF prednisone
|
Liquid pred
Lisacort
LODOTRA
Lodotra®|Sterapred®
Me-Korti
Merck brand OF prednisone
Merz brand OF prednisone
Metacortandracin
Meticorten
Mibe brand OF prednisone
Nisona
Nizon
Novoprednisone
NSC-10023
Nurison
Orasone
Origen Prednisone
Panafcort
Panasol
PARACORT
Parmenison
Pehacort
Pharmacia brand OF prednisone
PRD
Precort
Predeltin
PREDN
Predni tablinen
PREDNICEN-M
Prednicorm
Prednicort
Prednicot
Prednidib
Prednilonga
Predniment
Prednison
Prednison acsis
Prednison galen
Prednison hexal
Prednisona
Prednisona [INN-Spanish]
Prednisone
PREDNISONE INTENSOL
PREDNISONE TABLETS
Prednisonum
Prednisonum [INN-Latin]
Prednitone
Prednizon
Prednovister
Presone
Pronison
Pronisone
RAYOS
Rectodelt
Retrocortine
Schering-plough brand OF prednisone
Seatrace brand OF prednisone
SERVISONE
Solvay brand OF prednisone
Sone
Sterapred
Supercortil
Trommsdorff brand OF prednisone
Ultracorten
Ultracortene
Winpred
Wojtab
Zenadrid
|
|
24 |
|
Probucol |
Approved, Investigational |
Phase 4 |
|
23288-49-5 |
4912 |
Synonyms:
4,4'- (ISOPROPYLIDENEDITHIO)BIS(2,6-DI-TERT-BUTYLPHENOL)
4,4'-(Isopropylidenedithio)bis(2, 6-di-tert-butylphenol)
4,4'-(Isopropylidenedithio)bis(2,6-di-tert-butylphenol)
4,4'-(Isopropylidenedithio)bis[2, 6-di-tert-butylphenol]
Acetone bis(3,5-di-tert-butyl-4-hydroxyphenyl) mercaptole
Acetone, bis (3,5-di-tert-butyl-4-hydroxyphenyl) mercaptole
Acetone, bis(3,5-di-tert-butyl-4-hydroxyphenyl) mercaptole
Almirall brand OF probucol
Aventis brand OF probucol
Biphenabid
Bisbid
Bisphenabid
DH-581
|
DH-581|Lorelco®
Hoechst brand OF probucol
Lesterol
Lorelco
Lurselle
NSC-652160
NSC-86225
Panavir
PROBUCOL
Probucolum
Serterol
SINLESTAL
Superlipid
|
|
25 |
|
Cilostazol |
Approved, Investigational |
Phase 4 |
|
73963-72-1 |
2754 |
Synonyms:
3,4-Dihydro-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-2(1H)-quinolinone
6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-2(1H)-quinolinone
6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydrocarbostyril
6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-3,4-dihydro-1H-quinolin-2-one
CILOSTAZOL
Cilostazole
Cilostazolum
|
Cilostazolum [INN-Latin]
OPC-13013
OPC-13013|OPC-21|Pletal®
OPC-21
Pletaal
Pletal
|
|
26 |
|
Exenatide |
Approved, Investigational |
Phase 4 |
|
141758-74-9 |
45588096 |
Synonyms:
AC 2993
AC002993
AC-002993
AC2993
AC-2993
AC2993A
AC-2993A
AC-2993LAR
BYDUREON
BYDUREON BCISE
BYDUREON PEN
|
BYETTA
DA-3091
Exenatida
EXENATIDE
EXENATIDE SYNTHETIC
Exendin 4
EXENDIN-4
ITCA-650
LY2148568
LY-2148568
SYNTHETIC EXENDIN-4
|
|
27 |
|
Atorvastatin |
Approved |
Phase 4 |
|
134523-00-5 |
60823 |
Synonyms:
(3R,5R)-7-(2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoic acid
(3R,5R)-7-[2-(4-FLUOROPHENYL)-3-PHENYL-4-(PHENYLCARBAMOYL)-5-(PROPAN-2-YL)-1H-PYRROL-1-YL]-3,5-DIHYDROXYHEPTANOIC ACID
(R-(R*,r*))-2-(4-fluorophenyl)-b,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoate
(R-(R*,r*))-2-(4-fluorophenyl)-b,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoic acid
(R-(R*,r*))-2-(4-fluorophenyl)-b,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoate
(R-(R*,r*))-2-(4-fluorophenyl)-b,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoic acid
(R-(R*,r*))-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoate
(R-(R*,r*))-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoic acid
(R-(R*,r*))-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoate
(R-(R*,r*))-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoic acid
7-[2-(4-FLUORO-phenyl)-5-isopropyl-3-phenyl-4-phenylcarbamoyl-pyrrol-1-yl]-3,5-dihydroxy-heptanoate
7-[2-(4-FLUORO-phenyl)-5-isopropyl-3-phenyl-4-phenylcarbamoyl-pyrrol-1-yl]-3,5-dihydroxy-heptanoIC ACID
Anhydrous, atorvastatin calcium
Atogal
Atorlip
Atorpic
ATORVASTATIN
Atorvastatin acid
Atorvastatin calcium
Atorvastatin calcium anhydrous
Atorvastatin calcium hydrate
Atorvastatin calcium trihydrate
Atorvastatin, calcium salt
Atorvastatina
Atorvastatine
Atorvastatinum
Calcium anhydrous, atorvastatin
Calcium hydrate, atorvastatin
Calcium salt atorvastatin
Calcium trihydrate, atorvastatin
Calcium, atorvastatin
|
Cardyl
Faboxim
Hipolixan
Hydrate, atorvastatin calcium
LCF872
Lipitor
Lipitor®
Lipotropic
Lipovastatinklonal
Liprimar
Liptonorm
Lowden
Normalip
PREVENCOR
Sincol
Sortis
Sotis
TAHOR
Torvacard
Torvast
Totalip
Tozalip
Trihydrate, atorvastatin calcium
Tulip
Vastina
Xanator
Xarator
Xavator
ZARATOR
Zurinel
|
|
28 |
|
Indapamide |
Approved |
Phase 4 |
|
26807-65-8 |
3702 |
Synonyms:
CARDIDE SR
ETHIBIDE XL
HYPEN SR
Indapamid
Indapamida
Indapamide
Indapamidum
INDAXA 2.5
INDIPAM XL
KYD-041
Lozol
MAPEMID XL
|
Metindamide
NATRILIX
NATRILIX SR
Natrix
NINDAXA 2.5
OPUMIDE 2.5
RAWEL XL
S-1520
SE-1520
TENSAID XL
VARBIM XL
|
|
29 |
|
Verapamil |
Approved |
Phase 4 |
|
152-11-4, 52-53-9 |
2520 |
Synonyms:
Akilen
Anpec
ANSYR
Ansyr®|CP-165331 / CP-16533-1|Securon®
Apo-verap
Arpamyl
Arpamyl LP
BERKATENS
CALAN
CALAN SR
Calaptin
Calaptin 240 SR
Calcan
Cardiabeltin
Cardiagutt
Cardibeltin
Cardioprotect
Caveril
Civicor
Civicor retard
Coraver
CORDILOX
CORDILOX I.V.
CORDILOX MR 240
Cordilox SR
Corpamil
COVERA
COVERA-HS
CP-165331
CP-16533-1
CP-165331 / CP-16533-1
CP-16533-1Calan
CP-165331Verapamil
D-365
D-365Iproveratril
delta-365
Dexverapamil
Dignover
Dilacoran
Dilacoran hta
Drosteakard
Durasoptin
Elthon
ETHIMIL MR 240
Falicard
Finoptin
Flamon
GEANGIN
HALF SECURON SR
Harteze
Hexasoptin
Hexasoptin retard
Hormitol
Hydrochloride, verapamil
Ikacor
Ikapress
Inselon
Iproveratril
Isoptimo
ISOPTIN
Isoptin retard
ISOPTIN SR
Isoptine
Isoptino
Isotopin
Izoptin
Jenapamil
Lekoptin
Lodixal
LU-20175
Magotiron
Manidon
Manidon retard
MANIDON SR
Novapamyl LP
Novo-veramil
|
NSC-272306NA
NSC-272366
NSC-657799
Nu-verap
Ormil
Praecicor
Quasar
RANVERA MR
Rapam
Robatelan
Sandoz brand OF verapamil
SECURON
SECURON IV
SECURON MID
SECURON SR
Tarka
UNIVER
Univex
Vasolan
Vasomil
Vasopten
Verabeta
Veracaps SR
Veracim
Veracor
Verahexal
Veraloc
Veramex
Veramil
Verapamil
Vérapamil
Verapamil [Usan:Ban:Inn]
Verapamil acis
Verapamil al
Verapamil atid
Verapamil basics
Verapamil ebewe
VERAPAMIL HCL
Verapamil henning
Verapamil hydrochloride
Verapamil injection
Verapamil MSD
Verapamil NM
Verapamil NM pharma
Verapamil nordic
Verapamil PB
Verapamil riker
Verapamil sandoz brand
Verapamil SR
Verapamil verla
Verapamil-abz
Verapamilo
Verapamilo [INN-Spanish]
Verapamilum
Verapamilum [INN-Latin]
Verapin
Verapress 240 SR
VERAPRESS MR 240
Veraptin
Verasal
Vera-sanorania
Verasifar
Veratensin
VERA-TIL SR
Verdilac
VERELAN
VERELAN PM
Verelan SR
Verexamil
Veroptinstada
Verpamil
VERTAB SR 240
Vetrimil
Vortac
ZOLVERA
|
|
30 |
|
Trandolapril |
Approved |
Phase 4 |
|
87679-37-6 |
5484727 |
Synonyms:
1-(2-((1-(Ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydro-1H-indol-2-carboxylic acid
Abbott brand OF trandolapril
Alter brand OF trandolapril
Aventis brand OF trandolapril
Aventis pharma brand OF trandolapril
CI-907
CI-907|indolapril|Mavik®|RU-44570
Gopten
Hoechst brand OF trandolapril
INDOLAPRIL
|
Knoll brand OF trandolapril
Mavik
Odrik
RU-44570
Tarka
TRANDOLAPRIL
TRANDOLAPRILUM
Trandolaprilum [Latin]
Udrik
|
|
31 |
|
Saxagliptin |
Approved |
Phase 4 |
|
361442-04-8 |
11243969 |
Synonyms:
(1S,3S,5S)-2-((2S)-Amino(3-hydroxytricyclo(3.3.1.13,7)dec-1-yl)acetyl)-2-azabicyclo(3.1.0)hexane-3-carbonitrile
3-Hydroxyadamantylglycine-4,5-methanoprolinenitrile hydrate
BMS 477118
BMS-477118
BMS-477118|Onglyza®
|
BMS-477118-11
Onglyza
SAXAGLIPTIN
SAXAGLIPTIN ANHYDROUS
Saxagliptina
|
|
32 |
|
Gliclazide |
Approved |
Phase 4 |
|
21187-98-4 |
3475 |
Synonyms:
1-(3-Azabicyclo(3.3.0)oct-3-yl)-3-(p-tolylsulfonyl)urea
1-(3-Azabicyclo(3.3.0)oct-3-yl)-3-(p-tolylsulphonyl)urea
1-(Hexahydrocyclopenta(c)pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)urea
1-(Hexahydrocyclopenta(c)pyrrol-2(1H)-yl)-3-(p-tolylsulphonyl)urea
Alphapharm brand OF gliclazide
BILXONA
DACADIS MR
Diabrezide
Diaglyk
Diaikron
Diamicron
DIAMICRON MR
EDICIL
Gen gliclazide
Generics brand OF gliclazide
Gen-gliclazide
Genpharm brand OF gliclazide
GLICLAZIDA
Gliclazida [INN-Spanish]
GLICLAZIDE
Gliclazide servier brand
GLICLAZIDUM
Gliclazidum [INN-Latin]
Gliklazid
|
Glimicron
GLIMIL
Glyade
Glyclazide
Helsinn brand OF gliclazide
J3.151H
Mylan-Gliclazide
N-(4-Methylbenzenesulfonyl)-n'-(3-azabicyclo(3.3.0)oct-3-yl)urea
NAZDOL MR
Nordialex
novo Gliclazide
novo-Gliclazide
Novopharm brand OF gliclazide
PMS-Gliclazide
S-1702
S-852
SE-1702
Servier brand OF gliclazide
VAMJU
VITILE XL
ZICLASEG
ZICRON
ZICRON PR
|
|
33 |
|
Enalaprilat |
Approved |
Phase 4 |
|
76420-72-9 |
6917719 5462501 |
Synonyms:
1-(N-((S)-1-Carboxy-3-phenylpropyl)-L-alanyl)-L-proline dihydrate
Anhydrous enalaprilat citrate
Anhydrous, enalaprilat
Biovail brand OF enalaprilat anhydrous
Boehringer ingelheim brand OF enalaprilat anhydrous
Dihydrate, enalaprilat
Enalapril acid
Enalapril diacid
Enalapril teva
ENALAPRILAT
Enalaprilat anhydrous
Enalaprilat citrate, anhydrous
Enalaprilat dihydrate
Enalaprilat, (R)-isomer, anhydrous
|
Enalaprilate
Enalaprilatum
Enalaprilic acid
Enalapril-teva
EnalaprilTEVA
Merck frosst brand OF enalaprilat anhydrous
MK-421
MK-422
MSD Brand OF enalaprilat
N-[(1S)-1-Carboxy-3-phenylpropyl]-L-alanyl-L-proline
Pres IV
Teva brand OF enalaprilat
Vasotec
Xanef
|
|
34 |
|
Enalapril |
Approved, Vet_approved |
Phase 4 |
|
75847-73-3 |
40466924 5388962 5362032 |
Synonyms:
(S)-1-(N-(1-(Ethoxycarbonyl)-3-phenylpropyl)-L-alanyl)-L-proline
(S)-1-{(S)-2-[1-((S)-ethoxycarbonyl)-3-phenyl-propylamino]-propionyl}-pyrrolidine-2-carboxylate
(S)-1-{(S)-2-[1-((S)-ethoxycarbonyl)-3-phenyl-propylamino]-propionyl}-pyrrolidine-2-carboxylic acid
1-(N-((S)-1-Carboxy-3-phenylpropyl)-L-alanyl)-L-proline 1'-ethyl ester
Analapril
ánalapril
Bonuten
C09AA02
ENALADEX
Enaladex®|Vasotec®
Enalapril
Enalapril Bp
Enalapril maleate
Enalapril Richet
Enalaprila
|
Enalaprila [INN-Spanish]
Enalaprilat
Enalaprilum
Enalaprilum [INN-Latin]
EPL753
Gadopril
Kinfil
LEXXEL
Maleate, enalapril
Renitec
Renitek
VASERETIC
VASOTEC
Vasotec IV
|
|
35 |
|
Pentoxifylline |
Approved, Investigational |
Phase 4 |
|
6493-05-6 |
4740 |
Synonyms:
Agapurin
BL-191
BL-191|Trental®
C04AD03
EHT0201
NEOTREN MR
NSC-637086
Oxpentifylline
Pentoxifilina
|
Pentoxifyllin
Pentoxifylline
Pentoxifyllinum
Pentoxil
Torental
Trental
TRENTAL 100
TRENTAL 400
|
|
36 |
|
Canagliflozin |
Approved |
Phase 4 |
|
842133-18-0 |
74323022 24812758 |
Synonyms:
1-(GLUCOPYRANOSYL)-4-METHYL-3-(5-(4-FLUOROPHENYL)-2-THIENYLMETHYL)BENZENE
CANAGLIFLOZIN
CANAGLIFLOZIN ANHYDROUS
Canagliflozina
Invokana®|JNJ-28431754|TA-7284
|
JNJ-24831754-ZAE
JNJ-28431754
JNJ-28431754-AAA
TA-7284
|
|
37 |
|
Glucagon |
Approved |
Phase 4 |
|
16941-32-5 |
16133228 16186314 |
Synonyms:
[<sup>125</sup>I]-glucagon
GCG(53-81)
GLUCAGEN HYPOKIT
GLUCAGON
Glucagon (recombinant dna origin)
GLUCAGON EMERGENCY KIT
|
GLUCAGON RECOMBINANT
Glucagon, human
Glucagon, porcine
GLUCAGONE
GLUCAGONUM
HSQGTFTSDYSKYLDSRRAQDFVQWLMNT
|
|
38 |
|
Ertugliflozin |
Approved, Investigational |
Phase 4 |
|
1210344-57-2 |
75075340 44814423 |
Synonyms:
ERTUGLIFLOZIN
MK-8835
MK-8835|PF-04971729|Steglatro®
PF04971729
|
PF-04971729
PF-04971729-00
STEGLATRO
|
|
39 |
|
Liraglutide |
Approved |
Phase 4 |
|
204656-20-2 |
44147092 16134956 |
Synonyms:
ARG34LYS26-(N-Ε-(Γ-GLU(N-Α-HEXADECANOYL)))-GLP-1[7-37]
LIRAGLUTIDA
LIRAGLUTIDE
Liraglutide (genetical recombination)
Liraglutide (rDNA origin)
LIRAGLUTIDE RECOMBINANT
LIRAGLUTIDUM
N²⁶-(HEXADECANOYL-GAMMA-GLUTAMYLE)-[34-ARGININE]GLP-1-(7-37)-PEPTIDE
N²⁶-(N-HEXADECANOYL-L-GAMMA-GLUTAMYL)-[34-L-ARGININE]GLUCAGON-LIKE PEPTIDE 1-(7-37)-PEPTIDE
NN 2211
|
NN2211
NN-2211
NN-2211|NN2211|Victoza®
NN9924
NN-9924
NNC 90-1170
NNC-90-1170
SAXENDA
VICTOZA
|
|
40 |
|
Perindopril |
Approved |
Phase 4 |
|
82834-16-0, 107133-36-8 |
107807 |
Synonyms:
(2S,3AS,7as)-1-[(2S)-2-{[(2S)-1-ethoxy-1-oxopentan-2-yl]amino}propanoyl]octahydro-1H-indole-2-carboxylate
(2S,3AS,7as)-1-[(2S)-2-{[(2S)-1-ethoxy-1-oxopentan-2-yl]amino}propanoyl]octahydro-1H-indole-2-carboxylic acid
ACEON
COVERSYL
Coversyl®|Preterax®|S-9490
Erbumine, perindopril
MCN-A-2833
MCN-A-2833-109
Perindopril
|
Perindopril erbumine
PERINDOPRIL TERT-BUTYLAMINE
Perindoprilum
Perstarium
Pirindopril
PRETERAX
S-9490
S-9490-3
|
|
41 |
|
Dapagliflozin |
Approved |
Phase 4 |
|
461432-26-8 |
9887712 |
Synonyms:
(2S,3R,4R,5S,6R)-2-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-6- (hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
BMS-512148
BMS-512148|Farxiga®|Forxiga®
BMS-512148-05
|
Dapagliflozin
Dapagliflozina
FARXIGA
FORXIGA
|
|
42 |
|
Insulin lispro |
Approved |
Phase 4 |
|
133107-64-9 |
16132438 |
Synonyms:
ADMELOG
ADMELOG SOLOSTAR
HUMALOG
HUMALOG KWIKPEN
HUMALOG PEN
INS HUMALOG
INSULIN LISPRO
Insulin lispro (genetical recombination)
|
Insulin lispro (rDNA origin)
Insulin lispro protamine
Insulin lispro protamine recombinant
INSULIN LISPRO RECOMBINANT
insulin lispro-aabc
Insulin,lispro,human/rDNA
Insulin,lispro,protamine/rDNA
Insulina lispro
|
|
43 |
|
Insulin aspart |
Approved |
Phase 4 |
|
116094-23-6 |
16132418 |
Synonyms:
ASPART
ASPART INSULIN
B28-ASPART-INSULIN
B28-ASP-INSULIN
FIASP
FIASP FLEXTOUCH
FIASP PENFILL
INA-X14
INS NOVORAPID
INSULIN ASPART
Insulin aspart protamine
Insulin aspart protamine recombinant
INSULIN ASPART RECOMBINANT
|
INSULIN X14
INSULIN, ASP(B28)
Insulin, aspart protamine, human
Insulin, aspart, human
Insulin,aspart protamine
Insulina asparta
NOVOLOG
NOVOLOG FLEXPEN
NOVOLOG FLEXTOUCH
NOVOLOG INNOLET
NOVOLOG PENFILL
NOVORAPID
|
|
44 |
|
Dulaglutide |
Approved, Investigational |
Phase 4 |
|
923950-08-7 |
|
Synonyms:
Dulaglutida
DULAGLUTIDE
LY2189265
|
|
|
45 |
|
Lisinopril |
Approved, Investigational |
Phase 4 |
|
83915-83-7, 76547-98-3 |
5362119 |
Synonyms:
(S)-1-(N(2)-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline
[N2-[(S)-1-CARBOXY-3-phenylpropyl]-L-lysyl-L-proline
Acerbon
Acercomp
Alapril
Carace
Cipral
Cipril
Coric
Inhibril
Inopril
Linopril
Linvas
Lipril
Lisinal
LISINOPRIL
Lisinopril anhydrous
LISINOPRIL DIHYDRATE
LISINOPRIL HYDRATE
Lisinopril maleate (1:1)
Lisinopril sulfate (1:2)
Lisinoprilum
Lisipril
|
Lisoril
Lispril
Loril
LPR
Lysinopril
MK-521
Noperten
Novatec
Presiten
Prinil
Prinivil
Prinivil®|Zestril®
Prinzide
Renacor
Sinopril
Sinopryl
Tensopril
Tensyn
Tersif
Vivatec
Zestoretic
Zestril
|
|
46 |
|
Losartan |
Approved |
Phase 4 |
|
114798-26-4 |
3961 |
Synonyms:
(2-Butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methanol
[<sup>3</sup>H]-losartan
2-Butyl-4-chloro-1-((2'-(1H-etrazol-5-yl) (1,1'-biphenyl)-4-yl)methyl)-1H-imidazole-5-methanol
2-N-Butyl-4-chloro-5-hydroxymethyl-1-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]imidazole
Cozaar
Cozaar®|DuP 753|MK-954
DuP 753
DUP 89
DuP-753
HGP1405
HGP-1405
|
Hyzaar
Lortaan
LOSARTAN
Losartan monopotassium salt
Losartan potassium
Losartic
MK-954
Monopotassium salt, losartan
Potassium, losartan
Salt, losartan monopotassium
|
|
47 |
|
Valsartan |
Approved, Investigational |
Phase 4 |
|
137862-53-4 |
60846 |
Synonyms:
(S)-N-Valeryl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine
CGP-48933
CGP-48933|Diovan®|Prexxartan® (oral solution)
Diovan
EXFORGE
Kalpress
Miten
N-(p-(O-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine
Nisis
|
N-Pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine
N-Valeryl-N-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)valine
PREXXARTAN
Provas
Tareg
VAL489
Vals
VALSARTAN
|
|
48 |
|
Benazepril |
Approved, Investigational |
Phase 4 |
|
86541-75-5 |
5362124 |
Synonyms:
1H-1-BENZAZEPINE-1-ACETIC ACID, 3-((1-(ETHOXYCARBONYL)-3-PHENYLPROPYL)AMINO)-2,3,4,5-TETRAHYDRO-2-OXO-, (S-(R*,R*))-
Benazapril
BENAZEPRIL
Bénazépril
Benazepril HCl
Benazepril hydrochloride
Benazepril sandoz
Benazeprilum
Benazeprilum [Latin]
Benzazepril
Briem
C09AA07
|
CGS-14824-a
CGS-14824A
CGS-14824A|Lotensin®
CIB824
Cibacen
Cibacene
Cibacène
Forteekor
Labopal
Lotensin
LOTREL
|
|
49 |
|
Thiamine |
Approved, Investigational, Nutraceutical, Vet_approved |
Phase 4 |
|
70-16-6 |
1130 |
Synonyms:
[<sup>3</sup>H]-thiamine|[<sup>3</sup>H]vitamin B<sub>1</sub>
2-[3-[(4-AMINO-2-METHYL-PYRIMIDIN-5-YL)METHYL]-4-METHYL-1-THIA-3-AZONIACYCLOPENTA-2,4-DIEN-5-YL]ETHANOL
2-[3-[(4-AMINO-2-METHYL-PYRIMIDIN-5-YL)METHYL]-4-METHYL-THIAZOL-5-YL]ETHANOL
3-(4-AMINO-2-METHYL-PYRIMIDIN-5-YLMETHYL)-5-(2-HYDROXY-ETHYL)-4-METHYL-THIAZOL-3-IUM
ANEURIN
ANTIBERIBERI FACTOR
APATE DROPS
BEATINE
BEDOME
BEGIOLAN
BENERVA
BEQUIN
BERIN
BETALIN S
BETAXIN
BETHIAZINE
BEUION
BEVITEX
BEVITINE
BEWON
BIAMINE
BITHIAMIN
BIUNO
BIVATIN
BIVITA
CERNEVIT-12
CLOTIAMINA
ESKAPEN
|
ESKAPHEN
HYBEE
LIXA-BETA
METABOLIN
Mononitrate, thiamine
SLOWTEN
THD
THIADOXINE
THIAMIN
THIAMINAL
THIAMINE
Thiamine mononitrate
THIAMINE(1+)
THIAMINE(1+) ION
THIAMINIUM
Thiaminum
THIAMOL
THIAVIT
TIAMIDON
TIAMINA
TIAMINAL
TROPHITE
VETALIN S
VIB
VINOTHIAM
VITAMIN B 1
VITAMIN B1
VITANEURON
|
|
50 |
|
Alfacalcidol |
Approved, Nutraceutical |
Phase 4 |
|
41294-56-8 |
5282181 |
Synonyms:
(5Z,7E)-9,10-Seco-5,7,10(19)-cholestatrien-1a,3b-diol
(5Z,7E)-9,10-Seco-5,7,10(19)-cholestatrien-1alpha,3beta-diol
(5Z,7E)-9,10-Seco-5,7,10(19)-cholestatrien-1α,3β-diol
1 alpha-Hydroxycholecalciferol
1 alpha-Hydroxyvitamin D3
1a-Hydroxycholecalciferol
1a-Hydroxyvitamin D3
1a-Hydroxy-vitamin D3
1a-Hydroxyvitamin D3 / 1a-hydroxycholecalciferol
1alpha-Hydroxycholecalciferol
1alpha-Hydroxyvitamin D3
1alpha-Hydroxy-vitamin D3
1alpha-OHD3
1-alpha-Oxycholecalciferol
1-Hydroxycholecalciferol
1-Hydroxycholecalciferol, (1alpha,3alpha-(5Z,7E))-isomer
1-Hydroxycholecalciferol, (1beta)-(5Z)-isomer
1-Hydroxycholecalciferol, (1beta,3beta-(5E,7E))-isomer
1-Hydroxycholecalciferol, aluminum salt
1Α-hydroxycholecalciferol
|
1Α-hydroxyvitamin D3
1Α-hydroxy-vitamin D3
1Α-hydroxyvitamin D3 / 1α-hydroxycholecalciferol
9,10-Secocholesta-5,7,10(19)-triene-1a,3b-diol
9,10-Secocholesta-5,7,10(19)-triene-1alpha,3beta-diol
9,10-Secocholesta-5,7,10(19)-triene-1α,3β-diol
Alfacalcidol
Alfacalcidolum
AlfaD
Alphacalcidol
Alsiodol
Bondiol
Doss brand OF alfacalcidol
Eenalfadrie
EinsAlpha
Etalpha
Oksidevit
One-Alpha
Un-alfa
|
|
Interventional clinical trials:
(show top 50)
(show all 410)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Effects of SGLT2 Inhibition Treatment on Different Levels of Albuminuria in Patients With Type 2 Diabetes: a Prospective Interventional Study |
Unknown status |
NCT04127084 |
Phase 4 |
SGLT2 Inhibition |
2 |
Effect of Aldosterone Antagonism in the Reduction of Albuminuria and Diastolic Disfunction of Patients With Diabetic Nephropathy. |
Unknown status |
NCT00870402 |
Phase 4 |
Spironolactone;Placebo |
3 |
Clinical Trial Technology Development for the Validation of Surrogate Prognostic Markers in Patients With Diabetic Nephropathy |
Unknown status |
NCT01673204 |
Phase 4 |
Calcitriol;Placebo |
4 |
Phase 4 Study of Mechanisms of Low Protein Diet Supplemented With Ketoanalogs on Reducing Proteinuria and Maintaining Nutritional Status in Type 2 Diabetic Nephropathy |
Unknown status |
NCT01300273 |
Phase 4 |
|
5 |
A Prospective, Randomized, Two Period, With an Intermediate Wash Out Period, Cross-over Study to Compare the Effects of Either Combined Therapy With Ramipril and Clopidogrel or Ramipril Monotherapy on Oxidative Stress, Vascular Inflammation and Endothelial Dysfunction in Patients With Type 2 Diabetes and Diabetic Nephropathy |
Unknown status |
NCT01743014 |
Phase 4 |
Ramipril;Clopidogrel |
6 |
Effect of Intravenous and Oral Therapy With Sulodexide on Albuminuria in Type 2 Diabetic Patients |
Unknown status |
NCT01316068 |
Phase 4 |
intravenous use of sulodexide followed by oral use;use of sulodexide orally only |
7 |
Prevention of Renal Complications of Diabetes With Thiamine |
Unknown status |
NCT01725412 |
Phase 4 |
|
8 |
Comparative Effecacy of Metformin and Vildagliptin on Cardiometabolic Risk Factors, Metabolic Syndrome, and Diabetic Nephropathy Progression |
Unknown status |
NCT04485845 |
Phase 4 |
Vildagliptin;Captopril Tablets;MetFORMIN 500 Mg Oral Tablet |
9 |
Pentoxifylline Effect on Renal Function, Oxidative Stress, Inflammation, and Fibrosis Markers, and Quality of Life in Patients With Diabetic Nephropathy |
Unknown status |
NCT03664414 |
Phase 4 |
pentoxifylline |
10 |
Sympathetic Nervous System Inhibition for the Treatment of Diabetic Nephropathy |
Unknown status |
NCT01094769 |
Phase 4 |
Moxonidine;Placebo |
11 |
Effect of SGLT2 Inhibitor on Proteinuria in Diabetic Patients |
Unknown status |
NCT03573102 |
Phase 4 |
SGLT2 inhibitor;ACE inhibitor |
12 |
Renal Effects of Treatment With Empagliflozin Alone or in Combination With Semaglutide in Patients With Type 2 Diabetes and Albuminuria - A Double Blinded, Randomised, Placebo Controlled, Parallel, Single Center Study |
Unknown status |
NCT04061200 |
Phase 4 |
Semaglutide, 1.34 mg/mL;Empagliflozin 25 MG |
13 |
A Randomised, Double-blind, Placebo-controlled, Multicenter Trial to Investigate the Preventive Effect of BIBR277 (Telmisartan) in Diabetic Nephropathy on Transition From Incipient to Overt Nephropathy - Incipient to Overt : Angiotensin 2 Receptor Blocker, Telmisartan, Investigation on Type 2 Diabetic Nephropathy (INNOVATION Study - |
Completed |
NCT00153088 |
Phase 4 |
Telmisartan capsule 40 mg;Placebo;Telmisartan capsule 80 mg |
14 |
Lipo-prostaglandin E1 Improves Renal Hypoxia Evaluated by BOLD-MRI in Patients |
Completed |
NCT02628106 |
Phase 4 |
Lipo-PGE1 |
15 |
Nephropathy in Type 2 Diabetes: Effects of an Intensive Multifactorial Intervention Trial on Cardio-renal Events. |
Completed |
NCT00535925 |
Phase 4 |
SoC therapy;irbesartan;ramipril;hydrochlorothiazide;furosemide;amlodipine;atenolol;doxazosin;clonidine;insulin;simvastatin;fibrate;erythropoietin;aspirin |
16 |
Combined Diabetes-Renal Multifactorial Intervention In Patients With Advanced Diabetic Nephropathy (ADN) |
Completed |
NCT00708981 |
Phase 4 |
|
17 |
A Phase 4, Mono-center, Randomized, Open Label, Comparator-controlled, Parallel-group, Mechanistic Intervention Trial to Assess the Effect of 8-week Treatment With the Glucagon-like Peptide-1 Receptor Agonist Lixisenatide Versus Insulin Glulisine on Renal Physiology and Biomarkers in Insulin Glargine-treated Patients With Type 2 Diabetes Mellitus |
Completed |
NCT02276196 |
Phase 4 |
Lixisenatide;Insulin glulisine |
18 |
Effect of Enalapril and Losartan Association Therapy on Proteinuria and Inflammatory Biomarkers in Diabetic Nephropathy: a Clinical Trial on Type 2 Diabetes Mellitus |
Completed |
NCT00419835 |
Phase 4 |
enalapril;losartan |
19 |
FGF-23 and Endothelial Dysfunction in Diabetic Proteinuric Patients |
Completed |
NCT01703234 |
Phase 4 |
Ramipril |
20 |
Effect of Sarpogrelate On the Nephropathy in Type 2 Diabetes |
Completed |
NCT01869881 |
Phase 4 |
Anplag(Sarpogrelate);Placebo |
21 |
Effect of Renin Angiotensin System Blockade on CD95 and ADMA Levels in Type-2 Diabetic Patients With Proteinuria |
Completed |
NCT00893425 |
Phase 4 |
ramipril |
22 |
A 28-week, Randomised, Open-label, Parallel-Group, Multi-Center Study To Find the Effective Dose of Candesartan Cilexetil (Atacand) for Renoprotection in Korean Hypertensive Patients With Non-diabetic Nephropathy |
Completed |
NCT00573430 |
Phase 4 |
Candesartan Cilexetil;Candesartan Cilexetil 32mg |
23 |
Antiproteinuric Effect of Valsartan, Lisinopril and Valsartan Plus Lisinopril in Non-diabetic and Diabetic Renal Disease: a Randomized, Double Blind, Parallel Group, Controlled Trial With 5 Months Follow-up |
Completed |
NCT00171574 |
Phase 4 |
Valsartan;Valsartan plus HCTZ;Lisinopril |
24 |
A Prospective, Multi-center, Randomized, Open-label, Parallel-arm Controlled Study of Treating Type 2 Diabetic Nephropathy (Stage II-IV) With Alfacalcidol and Irbesartan |
Completed |
NCT03147677 |
Phase 4 |
Alfacalcidol;Irbesartan |
25 |
Effect of Urinary Alkalinization on Urine Uric Acid Precipitation and Crystallization in Adults With Type 1 DiabetesL a Open-label Trial |
Completed |
NCT02502071 |
Phase 4 |
sodium bicarbonate |
26 |
A Double-Blind Clinical Trial of Benfotiamine Treatment in Diabetic Nephropathy |
Completed |
NCT00565318 |
Phase 4 |
Benfotiamine;Placebo |
27 |
A Double-blind, Randomized, Placebo Controlled Trial of Allopurinol in Patients With Type 1 Diabetes and Microalbuminuria |
Completed |
NCT02829177 |
Phase 4 |
Allopurinol;Placebo |
28 |
A Multicenter, Randomized, Open-label, Parallel-group, Diabetic Diet-controlled Study to Evaluate the Efficacy and Safety of Compound α-Keto Acid Tablet in Combination With LPD in Delaying the Progress of Type 2 Diabetic Nephropathy |
Completed |
NCT00363987 |
Phase 4 |
Ketosteril® |
29 |
Spironolactone in Diabetic Nephropathy |
Completed |
NCT00317954 |
Phase 4 |
Spironolactone |
30 |
Renoprotective Effect of Nisoldipine and Lisinopril in Type 1 Diabetic Nephropathy |
Completed |
NCT00311870 |
Phase 4 |
nisoldipine;lisinopril |
31 |
Randomized Open Label Study Comparing the Metabolic Control of Kidney Transplant Recipients With Type 2 Diabetes Receiving Either Prograf or Neoral as Part of a ATG Induction, Prednisone Free and Monitored MMF Immunosuppressive Regimen. |
Completed |
NCT00296296 |
Phase 4 |
Cyclosporin;Tacrolimus |
32 |
Effect of Continuous Positive Airway Pressure on Albuminuria in Patients With Diabetic Nephropathy and Obstructive Sleep Apnea |
Completed |
NCT02816762 |
Phase 4 |
Pharmacological treatment |
33 |
"Safety and Efficacy of Acthar Gel on Albuminuria and Urinary Transforming Growth Factor Excretion in Type I or Type II Diabetics Requiring Medical Treatment of Hyperglycemia With Nephrotic Range Proteinuria: A Pilot Study" |
Completed |
NCT01028287 |
Phase 4 |
ACTH |
34 |
A Randomized, Control, Parallel, Open Label, Multi-centre Clinical Study to Evaluate the Efficacy and Safety of Cilostazol and Probucol in Combination on Patients With Diabetic Nephropathy |
Completed |
NCT01252056 |
Phase 4 |
Probucol;Probucol and Cilostazol |
35 |
Renal Denervation in Patients With Diabetic Nephropathy and Persistent Proteinuria |
Completed |
NCT01588795 |
Phase 4 |
Standardized antiproteinuric medication regimen includes an angiotensin receptor blocker , a diuretic , 25OH vitamin D3 and a statin |
36 |
The Effect of Paricalcitol Versus Placebo on Plasma N-Terminal-proBNP in Patients With Type 1 Diabetes Mellitus and Diabetic Nephropathy |
Completed |
NCT01331317 |
Phase 4 |
Paricalcitol |
37 |
Effects of Dapagliflozin Treatment on Urinary Proteomic Patterns in Patients With Type 2 Diabetes |
Completed |
NCT02914691 |
Phase 4 |
Dapagliflozine 10 mg once daily tablet treatment;Placebo identical once daily tablet treatment |
38 |
Effect of Exenatide on 24h-UAER in Patients With Diabetic Nephropathy: a 24- Week Study |
Completed |
NCT02690883 |
Phase 4 |
Exenatide;Lispro |
39 |
A Randomised, Double-Blind, Placebo-Controlled Study of Cilostazol 100 mg Twice Daily in the Treatment of Diabetic Nephropathy in Hong Kong Chinese |
Completed |
NCT00272831 |
Phase 4 |
Cilostazol;Placebo |
40 |
Effects of Doxazosin on Ambulatory Blood Pressure and Sympathetic Nervous Activity in Hypertensive Patients With Diabetic Nephropathy |
Completed |
NCT00295555 |
Phase 4 |
Effects of doxazosin on morning surge in diabetic patients |
41 |
Effects of Atorvastatin Versus Probucol on Low-Density Lipoprotein Subtype Distribution and Renal Function in Hyperlipidemic Patients With Non-Diabetic Nephropathy |
Completed |
NCT00276133 |
Phase 4 |
Effects of atorvastatin versus probucol on small dense LDL |
42 |
A Two-Phase Study for Primary and Secondary Prevention of Diabetic Nephropathy by Combined ACE Inhibition and Calcium Channel Blockade (BENEDICT) |
Completed |
NCT00235014 |
Phase 4 |
trandolapril;trandolapril/verapamil;placebo;verapamil |
43 |
A Phase IV, Randomized, Open-Label, Active Controlled Study to Compare the Effects of Tarka® and Lotrel® on Albuminuria in Hypertensive, Type 2 Diabetic Subjects With Diabetic Nephropathy |
Completed |
NCT00234871 |
Phase 4 |
trandolapril/verapamil;Lotrel (amlodipine/benazepril) |
44 |
A Single Arm Open Label Multicenter Interventional Study to Assess the Efficacy, Safety, and Tolerability of Every 4 Weeks Administration of Subcutaneous C.E.R.A. for the Treatment of Chronic Renal Anemia in Diabetic Nephropathy With Chronic Kidney Disease Stages III-IV Not on Dialysis, Not Currently Treated With ESA. |
Completed |
NCT01191983 |
Phase 4 |
Methoxy polyethylene glycol-epoetin beta [Mircera] |
45 |
A New Clinical Utility for Tubular Markers to Identify Kidney Responders to Saxagliptin Treatment in Patients With Diabetic Nephropathy |
Completed |
NCT04521049 |
Phase 4 |
Saxagliptin 5mg |
46 |
A Randomized, Double-blind, Comparator-controlled Trial to Assess the Effect of 12-week Treatment With Dapagliflozin Versus Gliclazide on Renal Physiology and Biomarkers in Metformin-treated Patients With Type 2 Diabetes Mellitus |
Completed |
NCT02682563 |
Phase 4 |
Dapagliflozin 10mg QD;Gliclazide 30mg QD |
47 |
Effect of Glucose in Dialysis Water in Diabetics With Chronic Renal Failure on Blood Pressure, Pulse Rate, Plasma Glucose, Plasma Concentrations of Insulin, Growth Hormone, Renin, Angiotensin II, Endothelin and Body Temperature |
Completed |
NCT00438503 |
Phase 4 |
|
48 |
Comparative Effects of add-on Pentoxifylline to Losartan Versus Increasing Dose of Losartan on Serum NT-PRO BNP and Proteinuria in Type 2 Diabetics With Nephropathy |
Completed |
NCT03006952 |
Phase 4 |
Pentoxifylline;Losartan |
49 |
A Prospective, Randomised, Double-blind, Double-dummy, Forced-titration, Multicentre, Parallel Group, One Year Treatment Trial to Investigate the Efficacy of Telmisartan 80 mg Versus Valsartan 160 mg in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy VIVALDI-Study |
Completed |
NCT00153023 |
Phase 4 |
Telmisartan;Valsartan |
50 |
A Prospective, Randomised, Double-blind, Double-dummy, Forced-titration, Multicentre, Parallel Group, One Year Treatment Trial to Compare MICARDIS® (Telmisartan) 80 mg Versus COZAAR® (Losartan) 100 mg, in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy (AMADEO Study) |
Completed |
NCT00168857 |
Phase 4 |
telmisartan;losartan |
Inferred drug relations via
UMLS
71
/
NDF-RT
50
:
benazepril
Benazepril hydrochloride
candesartan
candesartan cilexetil
Captopril
Enalapril
Enalapril Maleate
Enalaprilat
eprosartan
Eprosartan mesylate
Fosinopril
Fosinopril Sodium
irbesartan
Lisinopril
Losartan
|
Losartan Potassium
moexipril
Moexipril hydrochloride
olmesartan
Olmesartan medoxomil
Perindopril
Perindopril arginine
Perindopril Erbumine
quinapril
Quinapril hydrochloride
Ramipril
telmisartan
trandolapril
valsartan
|
Cell-based therapeutics:
Data from LifeMap, the Embryonic Development and Stem Cells Database
Stem-cell-based therapeutic approaches for Microvascular Complications of Diabetes 3:
Embryonic/Adult Cultured Cells Related to Microvascular Complications of Diabetes 3:
|